secwatch.observer — SEC 8-K summary
======================================

Issuer:     Propanc Biopharma, Inc. (PPCB)
CIK:        0001517681
Form:       8-K
Filed at:   2022-10-12T23:59:59+00:00
Accession:  0001493152-22-028230
Event type: debt
Sentiment:  negative
Materiality: 0.60
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Propanc Biopharma issues $53,750 convertible note to Red Road with 35% discount conversion
--------------------------------------------------------------------------------

- Principal $53,750, net proceeds $50,000 after $3,750 fees; maturity Oct 6, 2023; 8% interest.
- Conversion price set at 65% of average lowest 3 trading prices in prior 10 days (35% discount).
- Prepayment premiums range from 110% to 129% of face amount; conversion begins 180 days after issuance.
- Default includes failure to deliver shares, OTC delisting, or financial restatement; default amount 150%.
- Note sold in private placement under Section 4(a)(2) and Regulation D; proceeds for working capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517681/000149315222028230/0001493152-22-028230-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517681/000149315222028230/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-028230

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer